Searchable abstracts of presentations at key conferences in endocrinology

ea0065oc1.5 | Metabolism and Obesity | SFEBES2019

Prolyl-hydroxylase 3 maintains β-cell glucose-sensing under metabolic stress

Cuozzo Federica , Nasteska Daniela , Thakker Alpesh , Westbrook Rebecca , Bakar Rula Bany , Cantley James , Tennant Daniel , Hodson David J

Aims: Prolyl-4 hydroxylase domain protein 3 (PHD3) is an alpha ketoglutarate-dependent dioxygenase involved in the oxygen-dependent regulation of cell phenotype. While PHD3 has been reported to suppress insulin sensitivity in the liver, little is known about effects of the enzyme in insulin-secreting β-cells.Methods: βPHD3−/− mice were generated by crossing the Ins1Cre driver line with animals bearing a floxed Egln3</...

ea0063oc6.3 | Obesity | ECE2019

Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance

Castellanos Ashley , Quevedo Omar Guzman , Fenelon Valerie , Zizzari Philippe , Clark Samantha , Dupuy Nathalie , Bellocchio Luigi , Marsicano Giovanni , Cota Daniela

Bile acids (BA) are cholesterol-derived molecules that are mostly known for their involvement in lipid digestion and absorption. Recent evidence recognizes them as metabolic integrators able to reduce body weight (BW), increase energy expenditure (EE) and improve glycemic control by activating their specific receptor, the Takeda G protein-coupled receptor 5 (TGR5) in peripheral organs. These outcomes have increased importance in the context of diet-induced obesity and associat...

ea0063p60 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Adrenal morphology in a large cohort of adult subjects with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Oriolo Claudia , Gasparini Daniela Ibarra , Altieri Paola , Ruffilli Francesca , Corzani Francesca , Dalmazi Guido Di , Vicennati Valentina , Pagotto Uberto , Gambineri Alessandra

Introduction: The adrenal morphology in congenital adrenal hyperplasia (CAH) is poorly described in the literature, so that adrenal radiological evaluation is not recommended in patients with CAH. The aim of this study was to evaluate the adrenal morphology in a large cohort of adult patients with CAH due to 21-hydroxylase deficiency and its correlation with the subtype of CAH (non-classical-NCAH, simple virilizing-SV, or salt wasting-SW), the hormonal status and the treatment...

ea0063p334 | Reproductive Endocrinology 1 | ECE2019

Definition of hormonal cut-off values for discriminating polycystic ovary syndrome from non classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Oriolo Claudia , Menabo Soara , Gasparini Daniela Ibarra , Altieri Paola , Corzani Francesca , Baldazzi Lilia , Castelli Silvia , Pagotto Uberto , Gambineri Alessandra

Objective: The aim of this study was to define which hormonal cut-off values can discriminate polycystic ovary syndrome (PCOS) from non classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-NCAH).Patients and methods: We included 70 women in reproductive age who attended our Unit from 2003 to 2018 for a diagnosis of PCOS with a basal 17hydroxyprogesterone (17OHP) level in the follicular phase of the menstrual cycle ≥200 ng/d...

ea0063p948 | Diabetes, Obesity and Metabolism 3 | ECE2019

The relationship of vitamin D status, adherence to the Mediterranean diet and physical activity in obese children and adolescents

Simunovic Marko , Supe-Domic Daniela , Karin Zeljka , Degoricija Marina , Paradzik Martina , Bozic Josko , Unic Ivana , Skrabic Veselin

Background: Vitamin D deficiency has been associated with a wide range of chronic diseases, including childhood obesity. Prevalence of vitamin D deficiency in obese children and adolescents ranges from 6.5% to 57% depending on the population and criteria.Subjects and methods: This cross-sectional clinical study included 92 obese patients with BMI z score <2 and 39 healthy normal-weight subjects in the control group who were matched with the study gro...

ea0063p1022 | Interdisciplinary Endocrinology 2 | ECE2019

Influence of type 2 diabetes on androgen levels in women with Alzheimer’s disease

Vaňkova Marketa , Vacinova Gabriela , Hill Martin , Včelak Josef , Vejražkova Daniela , Bendlova Běla

Introduction: Alzheimer’s disease (AD) is a neurodegenerative disease that is manifested by progressive loss of cognitive function. Neuroactive steroids and their metabolites have an important regulatory role in the nervous system, affect neuronal plasticity, response to stress, learning and memory and have a neuroprotective effect. One of the not fully elucidated risk factors for AD is impaired glucose tolerance/type 2 diabetes (T2D). It is well known that lower androgen...

ea0049ep188 | Endocrine tumours and neoplasia | ECE2017

An elevated chromogranin A: is it always a tumor progression?-case report

Bursuc Anamaria , Daniela Belceanu Alina , Armasu Ioana , Tirnovan Mirela , Manolachie Adina , Crumpei Felicia , Ciobanu Delia , Leustean Letitia , Vulpoi Carmen

Introduction: Pancreatic neuroendocrine tumors (PNET) are rare, with an incidence of 1/100,000/year. Chromogranin A (CgA) is the most valuable marker in the diagnosis and monitoring of PNET. One of the disadvantages is its low specificity and the existence of a number of processes leading to an increase in its concentration, which often results in confusion and diagnostic difficulties.Case report: We present a 44-years-old female patient...

ea0049ep669 | Obesity | ECE2017

Menopause is a major determinant of endocannabinoid 2-arachidonoylglycerol plasma level and of its relevance as biomarker of dyslipidemia and insulin resistance in lean women

Fanelli Flaminia , Mezzullo Marco , Baccini Margherita , Casadio Elena , Gasparini Daniela Ibarra , Vicennati Valentina , Pasquali Renato , Pagotto Uberto

Context: The endocannabinoid system (ECS) hypertonicity contributes to obesity development and maintenance. Excess circulating levels of ECS mediator 2-arachidonoylglycerol (2AG) were reported in obese humans, however, unstandardized experimental settings (i.e. analytical conditions, sample size, concurrent diseases/medications, statistics, gender, body mass index (BMI) and age), clouded its role in dysmetabolism and its usefulness as biomarker. The study aimed at describing 2...

ea0049ep671 | Obesity | ECE2017

Endocannabinoid 2-arachidonoylglycerol plasma level is a BMI-independent biomarker of cardiometabolic risk in adult males with higher relevance in lean and aged conditions

Fanelli Flaminia , Mezzullo Marco , Baccini Margherita , Casadio Elena , Gasparini Daniela Ibarra , Vicennati Valentina , Pasquali Renato , Pagotto Uberto

Context: Ageing and obesity are similarly characterized by metabolic impairment in terms of visceral fat, dyslipidaemia, insulin resistance and hypertension. Obesity is featured by endocannabinoid system (ECS) hyperactivation. Increased levels of endocannabinoid 2-arachidonoylglycerol (2AG) found in obesity were variously associated to dysmetabolic features, however, it is not clear whether such associations exist in normal weight conditions. Moreover, ageing contribute in mod...

ea0049ep1073 | Pituitary - Clinical | ECE2017

Aggressive macroprolactinoma – exception to the rule

Belceanu Alina Daniela , Constantinescu Georgiana , Crumpei Iulia , Bursuc Anamaria , Rotariu Daniel , Constantinescu Aurora , Ciubotaru Vasile , Preda Cristina , Vulpoi Carmen

Background: Prolactinoma is the most frequent pituitary tumour. However, peculiar aspects may induce difficulties in their evolution and management. Malignant prolactinoma is exceptionally rare and it cannot be diagnosed on histological grounds alone. We report the case of a recurrent, possibly malignant macroprolactinoma.Case report: 46 years old female, addressed for bitemporal hemianopia, without other clinical signs. MRI confirmed a pituitary macroad...